Abstract
An acute hepatitis C virus (HCV) infection is an uncommonly encountered illness, because most patients are asymp¬tomatic. Patients infected with the HCV commonly tend to present asymptomatic because of spontaneous viral clear¬ance or chronic infection. Early antiviral treatment may be beneficial especially in symptomatic cases. Antiviral therapy with an (IFN)-based regimen is standard except in the instance of a human immunodeficiency virus (HIV) coinfection. The efficacy of HCV therapy has been restricted by the side effects of treatment. Advances in the treatment options of chronic HCV infection have resulted in the development of many new antiviral drugs that may allow for simplified and shortened treatments with increased tolerability and efficacy for patients with acute HCV infection. J Microbiol Infect Dis 2016;6(1): 40-44<br>İlkay Bozkurt,<br>Department of Clinical Microbiology and Infectious Diseases, Ondokuz Mayis University School of Medicine, Samsun, Turkey, Treatment of Acute Hepatitis C, İlkay Bozkurt, Department of Clinical Microbiology and Infectious Diseases, Ondokuz Mayis University School of Medicine, Samsun, Turkey, J Microbiol Infect Dis 2016;6(1):40-44 doi: 10.5799/ahinjs.02.2016.01.0214